Preparation and diabetic use of gibberellins

Details Preparation and diabetic use of gibberellins Preparation and diabetic use of gibberellins

2004-02-12

2008-10-14

Peselev, Elli (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

C514S025000, C514S033000

Reexamination Certificate

active

07435756

ABSTRACT:
The present invention relates to application of compounds of formula (1) (Gibberellins) and their derivatives for the preparation of a pharmaceutical composition or medicaments for the treatment of diabetes, its complications and associated conditions, including obesity, micro and macro vascular diseases, nephropathy, neuropathy, eye diseases, diabetic ulcerations and the like. The method results the normalization of serum glucose level and other physiological conditions

REFERENCES:
patent: 4424232 (1984-01-01), Parkinson
patent: 5580857 (1996-12-01), Oden
patent: 5591709 (1997-01-01), Lindenbaum
patent: 6121317 (2000-09-01), Wu et al.
patent: 6287800 (2001-09-01), Gallazzo et al.
patent: 6312663 (2001-11-01), Boykin, Jr.
patent: 0024951 (1983-12-01), None
patent: 58-152499 (1983-10-01), None
patent: 02-165775 (1990-06-01), None
patent: WO 94/26240 (1994-11-01), None
patent: WO 96/20703 (1996-07-01), None
patent: WO 97/02032 (1997-01-01), None
Davis, et al.Aloe Vera and Gibberellin Anti-inflammatory Activity in Diabetes, Journal of the American Podiatric Medical Association 79:1, 24-26 (Jan. 1989).
Int'l. Search Report in corresponding application PCT/AU02/01083, mailed Oct. 7, 2002.
Children's Medical Center at the University of Virginia,Pediatric Pharmacotherapy, 2:1-4 (1996).
Express Scripts, Inc., http://www.drugdigest.org/DD/PrintablePages/Comparisons/1,20038,8-21,00.html, printed on Mar. 8, 2005.
“Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications,” World Health Org., Dept. of Noncommunicable Disease Surveillance, Geneva 21-22 (1999).
Cardinal, et al., “Increased Susceptibility to Streptozotocin-Induced β-Cell Apoptosis and Delayed Autoimmune Diabetes in Alkylpurine-DNA-N-Glycosylase-Deficient Mice,”Molecular and Cellular Biology, 21:5605-5613 (2001).
Ramasamy, et al., “Protein Kinase C and the Sub-Sensitivity and Sub-Reactivity of the Diabetic Rat Prostate Gland to Noradrenaline,”European Journal of Pharmacology, 434:151-161 (2002).
Laposata, M.,SI Unit Conversion Guide, Boston:NEJM Books, 81-83.
Murray, et al., “Effect of Meals and Posture on Concentration of Substances in Blood,”Harper's Biochemistry, 24thEd., p. 830-832.
Dorland's Illustrated Medical Dictionary, 25thEd., Philadelphia:W. B. Saunders, 1673.
Sweetman, S.C. (Ed.), “Antidiabetics,”Martindale, The Complete Drug Reference, 33rdEd., London:Pharmaceutical Press, 315-316.
“Glucophage”,Glucolet Endcaps1561 (1996).
MIMS Annual, “Hypoglycaemic Agents,” 612, 614-618, 620 (2003).
Chen et al., “Duration of Streptozotocin-Induced Diabetes Differentially Affects p38-Mitogen-Activated Protein Kinase (MAPK) Phosphorylation in Renal and Vascular Dysfunction”Cardiovacular Diabetology4:3 (2005). Abstract.
Heilbron, I.M. (Ed.),Dictionary of Organic Compounds6thed, London:Chapman & Hall, 2741-2747 (1996).
Rolandsson, et al., “Streptozotocin Induced Diabetes in Minipig: A Case Report of a Possible Model for Type 1 Diabetes”Autoimmunity35:261-264 (2002). Abstract.
Loudon, M.Organic Chemistry, 3rdEd. Redwood City, CA: Benjamin/Cummings Publishing Co., Inc., 131, 739 (1995).
March, J.,Advanced Organic Chemistry, 4thEd. New York: J. Wiley and Sons, 423 (1992).
Roberts, J. et al.,Basic Principles of Organic Chemistry, New York: W. A. Benjamin Co., 148 (1964).
Loudon,Organic Chemistry, 3rdEd. Redwood City, CA: Benjamin/Cummings Publishing Co., Inc., 1343-1348 (1995).
Sharp,The Penguin Dictionary of Chemistry, 5thEd., Harmondsworth, England: Penguin Books, 193 (1983).
Shurtz-Swirski et al., “Involvement of Peripheral Polymorphonuclear Leukocytes in Oxidative Stress and Inflammation in Type 2 Diabetic Patients,”Diabetes Care, 24:104-110 (2001).
“Antidiabetic Drugs,”The Year's Drug News, Therapeutic TargetsBarcelona: Prous Science, 351-360 (1995).
Uvarov et al.,A Dictionary of Science, 4thEd., Harmondsworth, England: Penguin Books, 169 (1971).
MacRury et al., “Changes in Phagocytic Function With Glycaemic Control in Diabetic Patients,”J. Clin. Pathol. 42:1143-1147 (1989).
Benoit et al., “Insulin and Leptin as Adiposity Signals”,Recent Progress in Hormone Research, 59:267-285, 2004.
DCCT/EDIC Research Group, “Retinopathy and Nephropathy in Patients with Type 1 Diabetes Four Years after a Trial of Intensive Therapy”,New England Jour. Med., 342:381-389, 2000.
MacRury et al., “Changes in Phagocytic Function With Glycaemic Control in Diabetic Patients,”J. Clin. Pathol. 42:1143-1147, 1989.
Reichard et al., “The Effect of Long-Term Intensified Insulin Treatment on the Development of Microvascular Complications of Diabetes Mellitus”,New England Jour. Med., 329:304-309, 1993.
Webster's Collegiate Dictionary 855 (11thed. 2003).
Mander, Twenty Years of Gibberellin Research, Nat. Prod. Rep., 20, pp. 49-69 (2003).
Reeve et al., An Assessment of Gibberellin Structure-Activity Relationships, J. of Exper. Bot., 25(85), pp. 431-445 (1974).
Yang et al., Effects of Gibberellins on Seed Germination of Phytochrome-Deficient Mutants ofArabidopsis thaliana, Plant Cell Physiol., 36(7), pp. 1205-1211 (1995).
Kren et al.,Current Med. Chem., 8:1313-38 (2001).
Sembdner et al.,Acta Universitatis Nicolai Copernici, Nauki Matematyczno-Przyrodnicze37:177-181 (1976).
Andreoli, Thomas E. et al.,Cecil Essentials of Medicine, 4thEdition, W. B. Saunders Company, p. 536, (1997).
Loudon, G. Marc,Organic Chemistry, 4thEdition, Oxford University Press, pp. 1343-1348, (2002).

Affiliated with

Also associated with

Rating

Preparation and diabetic use of gibberellins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Preparation and diabetic use of gibberellins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preparation and diabetic use of gibberellins will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4004445